{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T01:24:48Z","timestamp":1784942688549,"version":"3.55.0"},"reference-count":68,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T00:00:00Z","timestamp":1655337600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Novartis Brazil"},{"name":"Novartis Brazil"},{"name":"Novartis Brazil"},{"name":"Novartis Brazil"},{"name":"Novartis Brazil"},{"name":"Novartis Brazil"},{"name":"Novartis Brazil"},{"name":"Novartis Brazil"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>Sickle cell disease (SCD) may cause several impacts to patients and the whole society. About 4% of the population has the sickle cell trait in Brazil, and 60,000 to 100,000 have SCD. However, despite recognizing the significant burden of disease, little is known about SCD costs.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Objective<\/jats:title>\n<jats:p>To estimate SCD societal costs based on disease burden modelling, under Brazilian societal perspective.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Methods<\/jats:title>\n<jats:p>A disease burden model was built considering the societal perspective and a one-year time horizon, including direct medical and indirect costs (morbidity and mortality). The sum of life lost and disability years was considered to estimate disability-adjusted life years (DALYs). Data from a public database (DATASUS) and the prevalence obtained from literature or medical experts were used to define complications prevalence and duration. Costs were defined using data from the Brazilian public healthcare system table of procedures and medications (SIGTAP) and the human capital method.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Results<\/jats:title>\n<jats:p>Annual SCD cost was 413,639,180 USD. Indirect cost accounted for the majority of burden (70.1% of the total; 290,158,365 USD <jats:italic>vs<\/jats:italic> 123,480,816 USD). Standard of care and chronic complications were the main source of direct costs among adults, while acute conditions were the main source among children. Vaso-occlusive crisis represented the complication with the highest total cost per year in both populations, 11,400,410 USD among adults and 11,510,960 USD among children.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec005\">\n<jats:title>Conclusions<\/jats:title>\n<jats:p>SCD management may impose an important economic burden on Brazilian society that may reach more than 400 million USD per year.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0269703","type":"journal-article","created":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T17:52:43Z","timestamp":1655401963000},"page":"e0269703","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":23,"title":["Economic burden of sickle cell disease in Brazil"],"prefix":"10.1371","volume":"17","author":[{"given":"Ana Cristina","family":"Silva-Pinto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando F.","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra Fatima Menosi","family":"Gualandro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia Belintani Blum","family":"Fonseca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmela Maggiuzzu","family":"Grindler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Homero C. R.","family":"Souza Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9190-5339","authenticated-orcid":true,"given":"Carolina Tosin","family":"Bueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodolfo D.","family":"Can\u00e7ado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2022,6,16]]},"reference":[{"issue":"1","key":"pone.0269703.ref001","first-page":"18010","article-title":"Sickle cell disease","volume":"4","author":"GJ Kato","year":"2018","journal-title":"Nat Rev"},{"issue":"February","key":"pone.0269703.ref002","first-page":"82","volume":"41","author":"J Mburu","year":"2019","journal-title":"Sickle cell disease: Reducing the global disease burden"},{"issue":"5","key":"pone.0269703.ref003","first-page":"439","article-title":"Hemoglobinopatias em rec\u00e9m-nascidos na regi\u00e3o sul do Tri\u00e2ngulo Mineiro, Brasil. Estudo transversal","volume":"133","author":"AM Carlos","year":"2015","journal-title":"Sao Paulo Med J"},{"issue":"2","key":"pone.0269703.ref004","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1590\/1982-0194201900028","article-title":"Preval\u00eancia da doen\u00e7a falciforme em adultos com diagn\u00f3stico tardio","volume":"32","author":"CNF Sarat","year":"2019","journal-title":"Acta Paul Enferm."},{"key":"pone.0269703.ref005","article-title":"Secretaria de Aten\u00e7\u00e3o \u00e0 Sa\u00fade","author":"Minist\u00e9rio da Sa\u00fade. (Brasil)","year":"2018","journal-title":"Protocolo Cl\u00ednico e Diretrizes Terap\u00eauticas da Doen\u00e7a Falciforme"},{"issue":"1","key":"pone.0269703.ref006","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.bjhh.2017.09.006","article-title":"Mortality in children, adolescents and adults with sickle cell anemia in Rio de Janeiro, Brazil","volume":"40","author":"C Lobo CL de","year":"2018","journal-title":"Hematol Transfus Cell Ther."},{"key":"pone.0269703.ref007","article-title":"Departamento de Aten\u00e7\u00e3o Especializada e Tem\u00e1tica","author":"Brasil. Minist\u00e9rio da Sa\u00fade. Secretaria de Aten\u00e7\u00e3o \u00e0 Sa\u00fade","year":"2015","journal-title":"Doen\u00e7a falciforme: diretrizes b\u00e1sicas da linha de cuidado"},{"issue":"12","key":"pone.0269703.ref008","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1016\/j.mayocp.2018.08.001","article-title":"Advances in the Treatment of Sickle Cell Disease","volume":"93","author":"S Kapoor","year":"2018","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"pone.0269703.ref009","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/s41573-018-0003-2","article-title":"Therapeutic strategies for sickle cell disease: towards a multi-agent approach","volume":"18","author":"MJ Telen","year":"2019","journal-title":"Nat Rev Drug Discov"},{"issue":"16","key":"pone.0269703.ref010","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1056\/NEJMra1510865","article-title":"Sickle Cell Disease","volume":"376","author":"FB Piel","year":"2017","journal-title":"N Engl J Med"},{"issue":"Supplement_1","key":"pone.0269703.ref011","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1182\/blood-2019-131721","article-title":"Relationship between Vaso-Occlusive Crises and Important Complications in Sickle Cell Disease Patients","volume":"134","author":"M Bailey","year":"2019","journal-title":"Blood"},{"issue":"9779","key":"pone.0269703.ref012","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1016\/S0140-6736(11)60054-8","article-title":"The Brazilian health system: History, advances, and challenges","volume":"377","author":"J Paim","year":"2011","journal-title":"Lancet"},{"issue":"1","key":"pone.0269703.ref013","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.bjhh.2016.09.008","article-title":"Mortality by sickle cell disease in Brazil","volume":"39","author":"GAO Arduini","year":"2017","journal-title":"Rev Bras Hematol Hemoter [Internet]"},{"issue":"1","key":"pone.0269703.ref014","first-page":"1","article-title":"An analysis of inpatient pediatric sickle cell disease: Incidence, costs, and outcomes","volume":"65","author":"LM Bou-Maroun","year":"2018","journal-title":"Pediatr Blood Cancer."},{"issue":"2","key":"pone.0269703.ref015","doi-asserted-by":"crossref","first-page":"475","DOI":"10.4314\/ahs.v14i2.27","article-title":"The rate and cost of hospitalisation in children with sickle cell anaemia and its implications in a developing economy","volume":"14","author":"SA Adegoke","year":"2014","journal-title":"Afr Health Sci"},{"issue":"3","key":"pone.0269703.ref016","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/pubmed\/fdu026","article-title":"A retrospective analysis of the cost of hospitalizations for sickle cell disease with crisis in England, 2010\/11","volume":"37","author":"E Pizzo","year":"2015","journal-title":"J Public Heal (United Kingdom)"},{"issue":"1","key":"pone.0269703.ref017","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1590\/1414-462x201700010209","article-title":"An\u00e1lise dos gastos das interna\u00e7\u00f5es hospitalares por anemia falciforme no estado da Bahia","volume":"25","author":"MMF Martins","year":"2017","journal-title":"Cad Sa\u00fade Coletiva"},{"issue":"6","key":"pone.0269703.ref018","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/ajh.21408","article-title":"The cost of health care for children and adults with sickle cell disease","volume":"84","author":"TL Kauf","year":"2009","journal-title":"Am J Hematol"},{"issue":"1","key":"pone.0269703.ref019","doi-asserted-by":"crossref","first-page":"52","DOI":"10.36469\/jheor.2020.12852","article-title":"Medical Resource Use and Costs of Treating Sickle Cell-related Vaso-occlusive Crisis Episodes: A Retrospective Claims Study","volume":"7","author":"N Shah","year":"2020","journal-title":"J Heal Econ Outcomes Res."},{"issue":"1","key":"pone.0269703.ref020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12913-021-07461-6","article-title":"Cost analysis of acute care resource utilization among individuals with sickle cell disease in a middle-income country","volume":"22","author":"C Lobo","year":"2022","journal-title":"BMC Health Serv Res"},{"issue":"8","key":"pone.0269703.ref021","doi-asserted-by":"crossref","first-page":"653","DOI":"10.2165\/11588380-000000000-00000","article-title":"Cost-of-illness studies: A guide to critical evaluation","volume":"29","author":"A Larg","year":"2011","journal-title":"Pharmacoeconomics"},{"key":"pone.0269703.ref022","author":"World Health Organization (WHO)","journal-title":"Disability-adjusted life years (DALYs) [Internet]"},{"key":"pone.0269703.ref023","author":"World Health Organization (WHO)","year":"2013","journal-title":"WHO methods and data sources for global burden of disease estimates 2000\u20132011 [Internet]"},{"key":"pone.0269703.ref024","author":"World Health Organization","year":"2018","journal-title":"WHO methods and data sources for global burden of disease estimates 2000\u20132016 [Internet]."},{"key":"pone.0269703.ref025","author":"Instituto Brasileiro de Geografia e Estat\u00edtica (IBGE)","year":"2017","journal-title":"T\u00e1buas completas de mortalidade [Internet]"},{"key":"pone.0269703.ref026","author":"Institute for Health Metrics and Evaluation","year":"2010","journal-title":"The global burden of disease: generating evidence, guiding policy."},{"issue":"28","key":"pone.0269703.ref027","first-page":"18","article-title":"Tratamento sequencial do carcinoma de c\u00e9lulas renais metast\u00e1tico com terapias alvo: custos associados ao manejo dos eventos adversos, sob as perspectivas p\u00fablica e privada, no Brasil","volume":"09","author":"RA Fernandes","year":"2011","journal-title":"C\u00e2ncer Hoje"},{"key":"pone.0269703.ref028","author":"Minist\u00e9rio do Planejamento Or\u00e7amento e Gest\u00e3o (Brasil). Instituto Brasileiro de Geografia e Estat\u00edtica (IBGE)","year":"2020","journal-title":"Indicadores IBGE\u2014Pesquisa Nacional por Amostra de Domic\u00edlios Cont\u00ednua Primeiro Trimestre de 2020 [Internet]"},{"issue":"4","key":"pone.0269703.ref029","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/ajh.26063","article-title":"Impact of sickle cell disease on patients\u02bc daily lives, symptoms reported, and disease management strategies: results from the international Sickle Cell World Assessment Survey (SWAY).","volume":"96","author":"I Osunkwo","year":"2021","journal-title":"Am J Hematol"},{"key":"pone.0269703.ref030","author":"Instituto Brasileiro de Geografia e Estat\u00edtica (IBGE)","year":"2018","journal-title":"Proje\u00e7\u00f5es da popula\u00e7\u00e3o [Internet]"},{"issue":"x x","key":"pone.0269703.ref031","article-title":"Sickle cell disease related mortality in Brazil, 2000\u20132018","author":"AH Santo","year":"2020","journal-title":"Hematol Transfus Cell Ther [Internet]"},{"key":"pone.0269703.ref032","author":"Minist\u00e9rio da Sa\u00fade (Brasil)","journal-title":"DATASUS\u2014Departamento de Inform\u00e1tica do SUS. Sistema de informa\u00e7\u00f5es de mortalidade [Internet]"},{"key":"pone.0269703.ref033","volume-title":"Epidemiologia das interna\u00e7\u00f5es hospitalares e tratamento farmacol\u00f3gico dos eventos agudos em doen\u00e7a falciforme","author":"M. Loureiro","year":"2006"},{"issue":"4","key":"pone.0269703.ref034","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.bcmd.2015.01.011","article-title":"Severity of Brazilian sickle cell disease patients: Severity scores and feasibility of the Bayesian network model use","volume":"54","author":"E Belini Junior","year":"2015","journal-title":"Blood Cells, Mol Dis"},{"key":"pone.0269703.ref035","volume-title":"Global Burden of Disease Study 2019 (GBD 2019) Disability Weights","author":"Global Burden of Disease Collaborative Network","year":"2020"},{"issue":"9859","key":"pone.0269703.ref036","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1016\/S0140-6736(12)61680-8","article-title":"Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010","volume":"380","author":"JA Salomon","year":"2012","journal-title":"Lancet"},{"issue":"2","key":"pone.0269703.ref037","first-page":"163","article-title":"Sequestro espl\u00eanico agudo em coorte de crian\u00e7as com anemia falciforme","volume":"85","author":"V. Rezende P","year":"2009","journal-title":"J Pediatr (Rio J)"},{"issue":"1","key":"pone.0269703.ref038","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1183\/09031936.00134410","article-title":"Pulmonary hypertension diagnosed by right heart catheterisation in sickle cell disease","volume":"39","author":"GHH Fonseca","year":"2012","journal-title":"Eur Respir J"},{"issue":"12","key":"pone.0269703.ref039","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1158\/1055-9965.2043.13.12","article-title":"Evaluation of breast cancer risk assessment techniques: a cost-effectiveness analysis","volume":"13","author":"EM Ozanne","year":"2004","journal-title":"Cancer Epidemiol biomarkers Prev"},{"issue":"1","key":"pone.0269703.ref040","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1186\/1472-6963-14-342","article-title":"The impact of preoperative patient characteristics on the cost-effectiveness of total hip replacement: a cohort study","volume":"14","author":"M Vogl","year":"2014","journal-title":"BMC Health Serv Res."},{"issue":"1","key":"pone.0269703.ref041","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4084\/mjhid.2019.010","article-title":"Chronic kidney disease amongst sickle cell anaemia patients at the University of Maiduguri Teaching Hospital, Northeastern Nigeria: A study of prevalence and risk factors","volume":"11","author":"AA Bukar","year":"2019","journal-title":"Mediterr J Hematol Infect Dis."},{"issue":"6","key":"pone.0269703.ref042","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1111\/bjh.15462","article-title":"Clinical and genetic ancestry profile of a large multi-centre sickle cell disease cohort in Brazil","volume":"182","author":"ABF Carneiro-Proietti","year":"2018","journal-title":"Br J Haematol"},{"issue":"5","key":"pone.0269703.ref043","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1590\/S1807-59322011000500015","article-title":"Low bone mass density is associated with hemolysis in brazilian patients with sickle cell disease","volume":"66","author":"G Baldanzi","year":"2011","journal-title":"Clinics"},{"issue":"2","key":"pone.0269703.ref044","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1600-0420.2005.00604.x","article-title":"Risk factors for conjunctival and retinal vessel alterations in sickle cell disease","volume":"84","author":"CSP Lima","year":"2006","journal-title":"Acta Ophthalmol Scand"},{"issue":"1","key":"pone.0269703.ref045","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.bjhh.2016.09.009","article-title":"Cholelithiasis and its complications in sickle cell disease in a university hospital","volume":"39","author":"RA Martins","year":"2017","journal-title":"Rev Bras Hematol Hemoter"},{"key":"pone.0269703.ref046","first-page":"54","article-title":"Estimated costs in treating sickle cell disease leg ulcer","author":"JAO Spira","year":"2020","journal-title":"Rev da Esc Enferm da USP"},{"issue":"6","key":"pone.0269703.ref047","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s00520-002-0429-1","article-title":"Resource utilization and cost of episodes of febrile neutropenia in children with acute leukemias and lymphomas","volume":"11","author":"VC Costa","year":"2003","journal-title":"Support Care Cancer"},{"issue":"1","key":"pone.0269703.ref048","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1590\/S1679-45082012000100017","article-title":"Predicting mortality and cost of hematopoeitic stem-cell transplantation","volume":"10","author":"FR Kerbauy","year":"2012","journal-title":"Einstein (S\u00e3o Paulo)"},{"issue":"2","key":"pone.0269703.ref049","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1136\/archdischild-2011-301419","article-title":"The cost effectiveness of treating paediatric cancer in low-income and middle-income countries: a case-study approach using acute lymphocytic leukaemia in Brazil and Burkitt lymphoma in Malawi","volume":"98","author":"N Bhakta","year":"2013","journal-title":"Arch Dis Child"},{"issue":"1","key":"pone.0269703.ref050","doi-asserted-by":"crossref","first-page":"31","DOI":"10.5581\/1516-8484.20110011","article-title":"Cost of the treatment of myelodisplastic syndrome in Brazil","volume":"33","author":"O Clark","year":"2010","journal-title":"Rev Bras Hematol Hemoter"},{"issue":"3","key":"pone.0269703.ref051","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/j.annemergmed.2020.08.009","article-title":"Trends in Sickle Cell Disease\u2013Related Mortality in the United States, 1979 to 2017","volume":"76","author":"AB Payne","year":"2020","journal-title":"Ann Emerg Med"},{"issue":"Supplement 1","key":"pone.0269703.ref052","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1182\/blood-2021-151098","article-title":"Sickle Cell Disease Mortality in Brazil: Real-World Evidence","volume":"138","author":"RD Can\u00e7ado","year":"2021","journal-title":"Blood"},{"issue":"1","key":"pone.0269703.ref053","first-page":"80","article-title":"Comparison of costs to the health sector of comprehensive and episodic health care for sickle cell disease patients","volume":"110","author":"YM Yang","year":"1995","journal-title":"Public Health Rep"},{"issue":"1","key":"pone.0269703.ref054","first-page":"44","article-title":"Hospital utilization patterns and costs for adult sickle cell patients in Illinois","volume":"112","author":"K Woods","year":"1997","journal-title":"Public Health Rep"},{"issue":"2","key":"pone.0269703.ref055","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.hoc.2015.11.005","article-title":"Sickle Cell Disease in Sub-Saharan Africa","volume":"30","author":"TN Williams","year":"2016","journal-title":"Hematol Oncol Clin North Am"},{"issue":"2","key":"pone.0269703.ref056","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/pbc.21781","article-title":"Healthcare utilization and expenditures for low income children with sickle cell disease","volume":"52","author":"JL Raphael","year":"2009","journal-title":"Pediatr Blood Cancer"},{"key":"pone.0269703.ref057","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/00043426-199909000-00010","article-title":"Costs, charges, and reimbursements for persons with sickle cell disease","volume":"21","author":"PJ Nietert","year":"1999","journal-title":"Journal of Pediatric Hematology\/Oncology"},{"issue":"5","key":"pone.0269703.ref058","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1002\/pbc.21335","article-title":"The British Childhood Cancer Survivor Study: Objectives, methods, population structure, response rates and initial descriptive information","volume":"50","author":"M Stevens","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"pone.0269703.ref059","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1097\/00043426-199811000-00003","article-title":"The costs of children with sickle cell anemia: Preparing for managed care","volume":"20","author":"JH Bilenker","year":"1998","journal-title":"Journal of Pediatric Hematology\/Oncology"},{"issue":"6","key":"pone.0269703.ref060","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/ajh.21443","article-title":"The cost of health care for patients with sickle cell disease","volume":"84","author":"SK Ballas","year":"2009","journal-title":"Am J Hematol"},{"key":"pone.0269703.ref061","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2147\/IJGM.S257340","article-title":"Patient-Reported Outcomes and Economic Burden of Adults with Sickle Cell Disease in the United States: A Systematic Review","volume":"13","author":"S Lee","year":"2020","journal-title":"Int J Gen Med"},{"issue":"November","key":"pone.0269703.ref062","doi-asserted-by":"crossref","first-page":"S420","DOI":"10.1016\/j.jval.2019.09.119","article-title":"Economic Burden of Sickle Cell Disease: a Targeted Global Literature Review","volume":"22","author":"A Naik","year":"2019","journal-title":"Value Heal"},{"issue":"8","key":"pone.0269703.ref063","first-page":"502","article-title":"Burden of Hemoglobinopathies (Thalassemia, Sickle Cell Disorders and G6PD Deficiency) in Iran, 1990\u20132010: findings from the Global Burden of Disease Study 2010","volume":"18","author":"N Rezaei","year":"2015","journal-title":"Arch Iran Med.Aug"},{"issue":"2","key":"pone.0269703.ref064","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1590\/S1516-84842008000200005","article-title":"Acute clinical events in patients with sickle cell disease: Epidemiology and treatment","volume":"30","author":"MM Loureiro","year":"2008","journal-title":"Rev Bras Hematol Hemoter"},{"issue":"5","key":"pone.0269703.ref065","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1590\/S1516-84842010000500010","article-title":"Morbimortalidade em doen\u00e7a falciforme","volume":"32","author":"PRJ Martins","year":"2010","journal-title":"Rev Bras Hematol Hemoter"},{"issue":"24","key":"pone.0269703.ref066","doi-asserted-by":"crossref","first-page":"3892","DOI":"10.1182\/blood-2013-05-498311","article-title":"Vaso-Occlusion in sickle cell disease: Pathophysiology and novel targeted therapies","volume":"122","author":"D Manwani","year":"2013","journal-title":"Blood"},{"issue":"3","key":"pone.0269703.ref067","first-page":"247","article-title":"Crises dolorosas na doen\u00e7a falciforme","volume":"29","author":"CLDC Lobo","year":"2007","journal-title":"Rev Bras Hematol Hemoter"},{"issue":"6","key":"pone.0269703.ref068","doi-asserted-by":"crossref","first-page":"357","DOI":"10.2165\/00019053-200220060-00001","article-title":"Sickle cell anaemia: Epidemiology and cost of illness","volume":"20","author":"PJ Nietert","year":"2002","journal-title":"Pharmacoeconomics"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0269703","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T17:54:10Z","timestamp":1655402050000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0269703"}},"subtitle":[],"editor":[{"given":"Mohamed A.","family":"Yassin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,6,16]]},"references-count":68,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,6,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0269703","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,16]]}}}